Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-19-000030
Filing Date
2019-09-12
Accepted
2019-09-12 21:57:57
Documents
1
Period of Report
2019-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156833986050609.html 4  
1 FORM 4 wf-form4_156833986050609.xml 4 3726
  Complete submission text file 0001615219-19-000030.txt   5186
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address
HANISH ARNOLD C (Reporting) CIK: 0001233253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 191091468

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations